These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
126 related articles for article (PubMed ID: 6929392)
1. Mutagenic activation of N-2-fluorenylacetamide and N-hydroxy-N-2-fluorenylacetamide in subcellular fractions from X/Gf mice. Reddy TV; Weisburger EK; Thorgeirsson SS J Natl Cancer Inst; 1980 Jun; 64(6):1563-9. PubMed ID: 6929392 [TBL] [Abstract][Full Text] [Related]
2. Species difference in liver microsomal and cytosolic enzymes involved in mutagenic activation of N-hydroxy-N-2-fluorenylacetamide. Kaneda S; Seno T; Takeishi K J Natl Cancer Inst; 1981 Sep; 67(3):549-55. PubMed ID: 6944527 [TBL] [Abstract][Full Text] [Related]
3. Metabolic activation of 2-aminofluorene, 2-acetylaminofluorene and N-hydroxy-acetylaminofluorene to bacterial mutagens with mussel (Mytilus galloprovincialis) and carp (Cyprinus carpio) subcellular preparations. Kurelec B; Krca S Comp Biochem Physiol C Comp Pharmacol Toxicol; 1987; 88(1):171-7. PubMed ID: 2890481 [TBL] [Abstract][Full Text] [Related]
4. Microsomal metabolism of the carcinogen, N-2-fluorenylacetamide, by the mammary gland and liver of female rats. I. Ring- and N-hydroxylations of N-2-fluorenylacetamide. Malejka-Giganti D; Decker RW; Ritter CL; Polovina MR Carcinogenesis; 1985 Jan; 6(1):95-103. PubMed ID: 3967341 [TBL] [Abstract][Full Text] [Related]
5. In vitro metabolism and mutagenic activation of 2-acetylaminofluorene by subcellular liver fractions from Cotton rats. Schut HA; Thorgeirsson SS Cancer Res; 1978 Aug; 38(8):2501-7. PubMed ID: 352509 [No Abstract] [Full Text] [Related]
6. Activation of the carcinogens N-hydroxy-N-2-fluorenylbenzamide and N-hydroxy-N-2-fluorenylacetamide via deacylations and acetyl transfers by rat peritoneal serosa and liver. Ritter CL; Malejka-Giganti D Carcinogenesis; 1994 Feb; 15(2):163-70. PubMed ID: 8313503 [TBL] [Abstract][Full Text] [Related]
7. Modulation of aromatic amine mutagenicity in Salmonella typhimurium with rat-liver 9000 g supernatant or monolayers of rat hepatocytes as an activation system. Holme JA; Haug LT; Dybing E Mutat Res; 1983 Apr; 117(1-2):113-25. PubMed ID: 6339903 [TBL] [Abstract][Full Text] [Related]
8. The importance of 2-aminofluorene in the mutagenic activation of 2-acetylaminofluorene. Robertson IG Mutat Res; 1986 Nov; 175(3):153-7. PubMed ID: 3534560 [TBL] [Abstract][Full Text] [Related]
9. Activation of N-acetoxy- and N-hydroxy-2-acetylaminofluorene to mutagenic and cytotoxic metabolites by V79 Chinese hamster cells. Glatt H; Oesch F Mutat Res; 1985 Apr; 149(2):265-9. PubMed ID: 3885026 [TBL] [Abstract][Full Text] [Related]
10. Developmental pattern of 3-methylcholanthrene-inducible mutagenic activation of N-2-fluorenylacetamide, 2-fluorenamine, and 2,4-diaminoanisole in the rabbit. Aune T; Dybing E; Thorgeirsson SS J Natl Cancer Inst; 1980 Apr; 64(4):765-9. PubMed ID: 6928989 [TBL] [Abstract][Full Text] [Related]
11. Sulfation in the metabolism and mutagenicity of N-hydroxy-2-fluorenylacetamide. Hinson JA; Andrews LS; Gillette JR Natl Cancer Inst Monogr; 1981 Dec; (58):113-6. PubMed ID: 6176868 [No Abstract] [Full Text] [Related]
12. Association between DNA strand breaks and specific DNA adducts in murine hepatocytes following in vivo and in vitro exposure to N-hydroxy-2-acetylaminofluorene and N-acetoxy-2-acetylaminofluorene. Vu VT; Møller ME; Grantham PH; Wirth PJ; Thorgeirsson SS Carcinogenesis; 1985 Jan; 6(1):45-52. PubMed ID: 4038475 [TBL] [Abstract][Full Text] [Related]
13. Mammary carcinogenesis in the rat by topical application of fluorenylhydroxamic acids and their acetates. Malejka-Giganti D; Rydell RE; Gutmann HR Cancer Res; 1977 Jan; 37(1):111-7. PubMed ID: 830400 [TBL] [Abstract][Full Text] [Related]
14. Mutagenic activation of N-hydroxy-2-acetylaminofluorene by developing epithelial cells of rat small intestine and effects of antioxidants. Schut HA; Thorgeirsson SS J Natl Cancer Inst; 1979 Dec; 63(6):1405-9. PubMed ID: 292812 [No Abstract] [Full Text] [Related]
15. Metabolic activation and genotoxicity of N-hydroxy-2-acetylaminofluorene and N-hydroxyphenacetin derivatives in Reuber (H4-II-E) hepatoma cells. Glowinski IB; Sanderson ND; Hayashi S; Thorgeirsson SS Cancer Res; 1984 Mar; 44(3):1098-104. PubMed ID: 6692396 [TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of disulfiram on rat mammary tumor induction by N-2-fluorenylacetamide and on its metabolic conversion to N-hydroxy-N-2-fluorenylacetamide. Malejka-Giganti D; McIver RC; Rydell RE J Natl Cancer Inst; 1980 Jun; 64(6):1471-7. PubMed ID: 6929383 [TBL] [Abstract][Full Text] [Related]
17. Detection of N-(deoxyguanosin-8-yl)-2-fluorenamine in DNA of peritoneal serosa and liver after intraperitoneal exposure of rats to N-hydroxy-N-2-fluorenylbenzamide or N-hydroxy-N-2-fluorenylacetamide. Malejka-Giganti D; Ritter CL; Fullerton NF; Beland FA Carcinogenesis; 1994 Dec; 15(12):2883-90. PubMed ID: 8001251 [TBL] [Abstract][Full Text] [Related]
18. Metabolism of the carcinogen N-hydroxy-N-2-fluorenylacetamide by rat peritoneal neutrophils. Malejka-Giganti D; Ritter CL; Willmott LD Carcinogenesis; 1993 Mar; 14(3):341-6. PubMed ID: 8453709 [TBL] [Abstract][Full Text] [Related]
19. Sex hormone-mediated effects on the phase I and phase II metabolism of N-2-fluorenylacetamide. Modulation of 9-hydroxylation. Malejka-Giganti D; Magat WJ; Decker RW Biochem Pharmacol; 1989 Apr; 38(7):1075-82. PubMed ID: 2495797 [TBL] [Abstract][Full Text] [Related]
20. The essential role of microsomal deacetylase activity in the metabolic activation, DNA-(deoxyguanosin-8-yl)-2-aminofluorene adduct formation and initiation of liver tumors by N-hydroxy-2-acetylaminofluorene in the livers of infant male B6C3F1 mice. Lai CC; Miller EC; Miller JA; Liem A Carcinogenesis; 1988 Jul; 9(7):1295-302. PubMed ID: 3383346 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]